Rafferty Asset Management, LLC Dexcom Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 207,286 shares of DXCM stock, worth $16.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

207,286

Previous 149,778 38.4%

Holding current value

$16.2 Million

Previous $17 Million 18.19%

% of portfolio

0.05%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $3.68 Million - $6.67 Million	57,508 Added 38.4%	207,286 $13.9 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $1.6 Million - $2.04 Million	14,548 Added 10.76%	149,778 $17 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $872,755 - $1.07 Million	7,641 Added 5.99%	135,230 $18.8 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $29,214 - $48,049	-387 Reduced 0.3%	127,589 $15.8 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $2.83 Million - $4.54 Million	32,941 Added 34.66%	127,976 $11.9 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $1.13 Million - $1.32 Million	10,084 Added 11.87%	95,035 $12.2 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $962,520 - $1.14 Million	9,255 Added 12.23%	84,951 $9.87 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $2.25 Million - $3.24 Million	-26,424 Reduced 25.88%	75,696 $8.57 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $487,418 - $601,245	-6,384 Reduced 5.88%	102,120 $8.23 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $6.14 Million - $12 Million	90,246 Added 494.28%	108,504 $8.09 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $713,126 - $986,915	7,580 Added 70.99%	18,258 $9.34 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $163,246 - $204,664	-1,257 Reduced 10.53%	10,678 $5.73 Million
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $126,451 - $169,668	1,185 Added 11.02%	11,935 $6.53 Million
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $112,333 - $149,698	-1,387 Reduced 11.43%	10,750 $4.59 Million
Q1 2021 May 10, 2021	BUY	$84.79 - $104.74 $18,823 - $23,252	222 Added 1.86%	12,137 $4.36 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $237,666 - $318,411	3,047 Added 34.36%	11,915 $4.41 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $7,067 - $8,358	-74 Reduced 0.83%	8,868 $3.66 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $560,484 - $941,950	8,942 New	8,942 $3.63 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $77,563 - $122,747	-1,623 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$36.62 - $57.29 $31,603 - $49,441	-863 Reduced 34.71%	1,623 $355,000
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $57,523 - $70,912	-1,619 Reduced 39.44%	2,486 $371,000
Q2 2019 Aug 09, 2019	BUY	$27.84 - $38.92 $114,283 - $159,766	4,105 New	4,105 $615,000

Others Institutions Holding DXCM

# of Institutions

1,016

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Dexcom Inc Transaction History